SeaStar Medical Holding Operating Income 2021-2025 | ICU
SeaStar Medical Holding operating income from 2021 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
SeaStar Medical Holding Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-18 |
| 2023 | $-14 |
| 2022 | $-12 |
| 2021 | $-4 |
| 2020 | $0 |
|
SeaStar Medical Holding Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-4 |
| 2025-06-30 | $-2 |
| 2025-03-31 | $-4 |
| 2024-12-31 | $-5 |
| 2024-09-30 | $-4 |
| 2024-06-30 | $-5 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $-3 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-5 |
| 2022-12-31 | $-8 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-1 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.009B | $0.000B |
| SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $152.395B | 27.66 |
| HCA Healthcare (HCA) | United States | $117.237B | 18.18 |
| CVS Health (CVS) | United States | $96.896B | 11.14 |
| Elevance Health (ELV) | United States | $73.839B | 11.01 |
| Cencora (COR) | United States | $68.317B | 21.55 |
| Natera (NTRA) | United States | $27.260B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.065B | 17.59 |
| DiDi Global (DIDIY) | China | $20.991B | 19.39 |
| Viatris (VTRS) | United States | $16.516B | 6.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.880B | 0.00 |
| Medpace Holdings (MEDP) | United States | $15.247B | 37.85 |
| Solventum (SOLV) | United States | $13.352B | 12.96 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $11.747B | 0.00 |
| ICON (ICLR) | Ireland | $11.741B | 11.65 |
| Revvity (RVTY) | United States | $11.283B | 19.63 |
| Charles River Laboratories (CRL) | United States | $9.041B | 17.41 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| Avantor (AVTR) | United States | $7.357B | 11.24 |
| BrightSpring Health Services (BTSG) | United States | $6.918B | 41.25 |
| HealthEquity (HQY) | United States | $6.768B | 25.31 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.996B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.813B | 38.16 |
| PACS (PACS) | United States | $5.774B | 35.11 |
| Sotera Health (SHC) | United States | $4.943B | 23.84 |
| Alignment Healthcare (ALHC) | United States | $4.232B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.016B | 18.82 |
| GeneDx Holdings (WGS) | United States | $2.430B | 42.68 |
| Organon (OGN) | United States | $2.106B | 2.22 |
| Establishment Labs Holdings (ESTA) | United States | $1.928B | 0.00 |
| Progyny (PGNY) | United States | $1.890B | 37.15 |
| Pediatrix Medical (MD) | United States | $1.789B | 10.68 |
| Surgery Partners (SGRY) | United States | $1.737B | 22.38 |
| Ardent Health (ARDT) | United States | $1.229B | 4.01 |
| InnovAge Holding (INNV) | United States | $1.014B | 149.40 |
| CareDx (CDNA) | United States | $0.944B | 15.42 |
| Teladoc Health (TDOC) | United States | $0.839B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.777B | 12.72 |
| Nutex Health (NUTX) | United States | $0.721B | 5.51 |
| Omada Health (OMDA) | United States | $0.694B | 0.00 |
| Embecta (EMBC) | United States | $0.620B | 3.46 |
| Sonida Senior Living (SNDA) | United States | $0.603B | 0.00 |
| Enhabit (EHAB) | United States | $0.558B | 25.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.548B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.464B | 8.53 |
| CryoPort (CYRX) | United States | $0.431B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.334B | 5.37 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Agilon Health (AGL) | United States | $0.262B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.259B | 0.00 |
| Oncology Institute (TOI) | United States | $0.241B | 0.00 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| LifeMD (LFMD) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| DocGo (DCGO) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.022B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.93 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |